Home / Stocks / PATH

UiPath (PATH, Systems Software) Stock Valuation & Fair Value Mixed on our tests

UiPath (PATH, Systems Software) trades at a blended P/E of 17.1, about 71% below its historical normal valuation, with a forward growth estimate of 14.3% and a PEG of 1.20. Analysts' one-year estimates have been hit 25% of the time. Priced at its historical normal P/E of 59.7 on the same blended earnings, the 2026-10-02 close of $13.12 corresponds to about $45.70 a share. This is a valuation reference, not a price target.

Blended P/E
17.1
Normal P/E
59.7
PEG
1.20
Fwd growth
14.3%
Div yield
0.0%
RSI (14)
47.9
Neutral
Technical context
  • Price $13.48 at the 2026-10-09 close, 2.0% above the 20-day average ($13.22) and 8.4% below the 50-day ($14.72).
  • RSI (14) at 47.9.
  • 52-week range $9.38 to $19.29: the price is 30.1% below the high and 43.7% above the low.

The Street vs SeerForecast

Wall Street's mean price target for PATH is $15.50 across 17 analysts, 15.0% above the current price. The average analyst rating is Hold. Our SeerForecast read of the same stock, formed without analyst targets: mixed on our tests. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from weak on forward returns (2026-08-27) to mixed on our tests (2026-10-05). New rating rules took effect in the week of 2026-09-28, and this rating moved across that change, so part of the move may come from the new rules rather than the company.

Blended P/E and rating by weekBlended P/E moved from 22.1 to 17.1 between 2026-08-27 and 2026-10-02, against a normal P/E of 59.7, with 3 rating changes over 14 recorded weeks.2026-08-27: P/E 22.1, Weak on forward returns, recalculated for the week of 2026-08-272026-08-28: P/E 22.1, Weak on forward returns, recalculated for the week of 2026-08-282026-08-28: P/E 22.1, Weak on forward returns, recalculated for the week of 2026-08-302026-08-28: P/E 23.9, Weak on forward returns, recorded live 2026-08-312026-09-04: P/E 23.9, Weak on forward returns, recalculated for the week of 2026-09-052026-09-04: P/E 19.9, Mixed on our tests, recorded live 2026-09-072026-09-11: P/E 19.9, Mixed on our tests, recalculated for the week of 2026-09-122026-09-11: P/E 18.1, Mixed on our tests, recorded live 2026-09-142026-09-18: P/E 18.1, Mixed on our tests, recalculated for the week of 2026-09-192026-09-18: P/E 17.6, Mixed on our tests, recorded live 2026-09-212026-09-25: P/E 17.6, Mixed on our tests, recalculated for the week of 2026-09-262026-09-25: P/E 16.3, Favorable on our tests, recorded live 2026-09-282026-10-02: P/E 16.3, Favorable on our tests, recalculated for the week of 2026-10-032026-10-02: P/E 17.1, Mixed on our tests, recorded live 2026-10-0520.040.0Aug 27Sep 5Sep 14Sep 23Oct 2Normal P/E 59.7
Favorable on our testsMixed on our testsWeak on forward returns

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-08-27P/E 22.1-63%Weak on forward returns (recalculated)
2026-08-31P/E 23.9-60%Weak on forward returns
2026-09-07P/E 19.9-67%Mixed on our tests
2026-09-28P/E 16.3-73%Favorable on our tests (across a rating rules change)
2026-10-05P/E 17.1-71%Mixed on our tests ← now
Show all 14 weeks
WeekBlended P/EPremium to normal P/ERating
2026-08-27P/E 22.1-63%Weak on forward returns (recalculated)
2026-08-28P/E 22.1-63%Weak on forward returns (recalculated)
2026-08-30P/E 22.1-63%Weak on forward returns (recalculated)
2026-08-31P/E 23.9-60%Weak on forward returns
2026-09-05P/E 23.9-60%Weak on forward returns (recalculated)
2026-09-07P/E 19.9-67%Mixed on our tests
2026-09-12P/E 19.9-67%Mixed on our tests (recalculated)
2026-09-14P/E 18.1-70%Mixed on our tests
2026-09-19P/E 18.1-70%Mixed on our tests (recalculated)
2026-09-21P/E 17.6-71%Mixed on our tests
2026-09-26P/E 17.6-71%Mixed on our tests (recalculated)
2026-09-28P/E 16.3-73%Favorable on our tests (across a rating rules change)
2026-10-03P/E 16.3-73%Favorable on our tests (recalculated)
2026-10-05P/E 17.1-71%Mixed on our tests ← now

Frequently asked questions

Is UiPath stock overvalued?

At a blended P/E of 17.1 versus its historical normal P/E of 59.7, UiPath trades about 71% below its typical valuation, with a PEG of 1.20 on 14.3% forward growth. tickerseer currently rates it mixed on our tests.

What is UiPath's fair value and PEG?

UiPath trades at a blended P/E of 17.1 against a historical normal P/E of 59.7, a PEG of 1.20, and a forward growth estimate of 14.3%. Priced at its historical normal P/E of 59.7 on the same blended earnings, the 2026-10-02 close of $13.12 corresponds to about $45.70 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of UiPath changed?

tickerseer's rating moved from weak on forward returns (2026-08-27) to mixed on our tests (2026-10-05). New rating rules took effect in the week of 2026-09-28, and this rating moved across that change, so part of the move may come from the new rules rather than the company.

What is the analyst price target for UiPath?

The mean Wall Street price target for UiPath is $15.50 across 17 analysts, 15.0% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Systems Software. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.